The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1384
In Brief: 5-HTP for Depression
Download PDF:   US English
Med Lett Drugs Ther. 2012 Feb 20;54(1384):16
Disclosures
Objective(s)
 Select a term to see related articles  5-HTP   Depression   L-tryptophan 

A Medical Letter reader asked about the use of the nutritional supplement 5-hydroxytryptophan (5-HTP) for treatment of depression. It is sold in health food stores, pharmacies and on-line for many indications including depression, mood enhancement, emotional well being, and promotion of normal sleep.

5-HTP is the intermediate metabolite in the biosynthesis of serotonin from L-tryptophan.1 Many small studies in the 1970’s and 1980’s found 5-HTP helpful in the treatment of depression, but a Cochrane Review of 108 studies in patients with depression or dysthymia using 5-HTP or L-tryptophan found that the quality of the data was insufficient to establish the efficacy or safety of these products.2

In 1989, contaminated L-tryptophan supplements were implicated as the causative agent in an outbreak of eosinophilia-myalgia syndrome (EMS), which was associated with some deaths. There is no evidence that 5-HTP could cause the syndrome.

There is no acceptable evidence that 5-HTP or L-tryptophan offers any advantage over a selective-serotonin reuptake inhibitor (SSRI) for treatment of depression. Taking 5-HTP or L-tryptophan in addition to an SSRI could cause serotonin syndrome.

There is no good reason to take 5-HTP or L-tryptophan.

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article